InMode (INMD) Set to Announce Earnings on Thursday

InMode (NASDAQ:INMD) will be issuing its quarterly earnings data before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.40 per share for the quarter. InMode has set its FY24 guidance at $2.53-2.57 EPS.Parties interested in listening to the company’s conference call can do so using this link.

InMode (NASDAQ:INMD) last posted its quarterly earnings data on Tuesday, February 13th. The healthcare company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.05. The company had revenue of $126.80 million during the quarter, compared to analyst estimates of $124.77 million. InMode had a net margin of 40.22% and a return on equity of 29.80%. The business’s revenue for the quarter was down 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.69 EPS. On average, analysts expect InMode to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

InMode Price Performance

Shares of INMD opened at $17.36 on Thursday. InMode has a 12-month low of $16.96 and a 12-month high of $48.25. The stock has a market capitalization of $1.46 billion, a P/E ratio of 7.55 and a beta of 2.16. The firm’s 50 day moving average is $20.57 and its 200-day moving average is $21.69.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Barclays cut their price objective on InMode from $34.00 to $33.00 and set an “overweight” rating for the company in a research report on Friday, April 12th. UBS Group boosted their price objective on InMode from $24.00 to $26.00 and gave the stock a “neutral” rating in a report on Wednesday, February 14th. Finally, Needham & Company LLC reissued a “hold” rating on shares of InMode in a research report on Tuesday, April 9th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $32.80.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.